Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis

被引:2
|
作者
Maraolo, Alberto E. [1 ]
Ong, David S. Y. [2 ,3 ]
机构
[1] Cotugno Hosp, Div Infect Dis 1, Via Gaetano Quagliariello 54, I-80131 Naples, Italy
[2] Franciscus Gasthuis & Vlietland, Dept Med Microbiol & Infect Control, Rotterdam, Netherlands
[3] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands
关键词
Acinetobacter baumannii; Bayesian; Carbapenem resistance; Meta-analysis; Posterior probabilities; Systematic review;
D O I
10.1016/j.cmi.2023.05.036
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1208 / 1210
页数:3
相关论文
共 50 条
  • [1] Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
    Park, So Yeon
    Si, Hye Jun
    Eom, Joong Sik
    Lee, Jin Seo
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (12) : 5977 - 5985
  • [2] Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
    Sirijatuphat, Rujipas
    Thamlikitkul, Visanu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5598 - 5601
  • [3] Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
    Sirijatuphat, Rujipas
    Thawornkaew, Supawas
    Ruangkriengsin, Darat
    Thamlikitkul, Visanu
    ANTIBIOTICS-BASEL, 2022, 11 (12):
  • [4] A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
    Katip, Wasan
    Uitrakul, Suriyon
    Oberdorfer, Peninnah
    ANTIBIOTICS-BASEL, 2020, 9 (10): : 1 - 11
  • [5] Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
    Huang, Chienhsiu
    Chen, Ihung
    Tang, Tiju
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [6] The effectiveness of colistin/levofloxacin compared to colistin/meropenem in the treatment of ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii: a randomized controlled clinical trial
    Momenzadeh, Mahnaz
    Soltani, Rasool
    Shafiee, Fatemeh
    Hakamifard, Atousa
    Pourahmad, Morteza
    Abbasi, Saeed
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2023, 18 (01) : 39 - 48
  • [7] Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
    Paul, Mical
    Daikos, George L.
    Durante-Mangoni, Emanuele
    Yahav, Dafna
    Carmeli, Yehuda
    Benattar, Yael Dishon
    Skiada, Anna
    Andini, Roberto
    Eliakim-Raz, Noa
    Nutman, Amir
    Zusman, Oren
    Antoniadou, Anastasia
    Pafundi, Pia Clara
    Adler, Amos
    Dickstein, Yaakov
    Pavleas, Ioannis
    Zampino, Rosa
    Daitch, Vered
    Bitterman, Roni
    Zayyad, Hiba
    Koppel, Fidi
    Levi, Inbar
    Babich, Tanya
    Friberg, Lena E.
    Mouton, Johan W.
    Theuretzbacher, Ursula
    Leibovici, Leonard
    LANCET INFECTIOUS DISEASES, 2018, 18 (04): : 391 - 400
  • [8] Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
    Zhan, Yangyang
    Mao, Wenchao
    Zhao, Changyun
    Lu, Difan
    Chen, Changqin
    Hu, Weihang
    Yang, Qi
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [9] Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
    Garnacho-Montero, Jose
    Amaya-Villar, Rosario
    Gutierrez-Pizarraya, Antonio
    Espejo-Gutierrez de Tena, Esther
    Luisa Artero-Gonzalez, M.
    Corcia-Palomo, Yael
    Bautista-Paloma, Javier
    CHEMOTHERAPY, 2013, 59 (03) : 225 - 231
  • [10] Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
    Katip, Wasan
    Oberdorfer, Peninnah
    PHARMACEUTICS, 2021, 13 (02) : 1 - 9